Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Page 1
Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years.
Little M, Gray AM, Altman DG, Benedetto U, Flather M, Gerry S, Lees B, Murphy J, Gaudino M, Taggart DP; Arterial Revascularization Trial Investigators. Little M, et al. Among authors: altman dg. Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):324-332. doi: 10.1093/ehjqcco/qcab004. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 33502466 Free PMC article.
We used data from the Arterial Revascularization Trial (ART) to assess long-term cost-effectiveness of BITA grafting compared to SITA grafting from an English health system perspective. ...
We used data from the Arterial Revascularization Trial (ART) to assess long-term cost-effectiveness of BITA grafting compared to SITA …
Fetal growth velocity standards from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project.
Ohuma EO, Villar J, Feng Y, Xiao L, Salomon L, Barros FC, Cheikh Ismail L, Stones W, Jaffer Y, Oberto M, Noble JA, Gravett MG, Wu Q, Victora CG, Lambert A, Di Nicola P, Purwar M, Bhutta ZA, Kennedy SH, Papageorghiou AT; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st Project). Ohuma EO, et al. Am J Obstet Gynecol. 2021 Feb;224(2):208.e1-208.e18. doi: 10.1016/j.ajog.2020.07.054. Epub 2020 Aug 5. Am J Obstet Gynecol. 2021. PMID: 32768431 Free PMC article.
However, velocity growth slowed down rapidly for head circumference, biparietal diameter, occipitofrontal diameter, and femur length, with an almost linear reduction toward term that was more marked for femur length. Conversely, abdominal circumference velocity remained re …
However, velocity growth slowed down rapidly for head circumference, biparietal diameter, occipitofrontal diameter, and femur length, with a …
Reporting of randomized factorial trials was frequently inadequate.
Kahan BC, Tsui M, Jairath V, Scott AM, Altman DG, Beller E, Elbourne D. Kahan BC, et al. Among authors: altman dg. J Clin Epidemiol. 2020 Jan;117:52-59. doi: 10.1016/j.jclinepi.2019.09.018. Epub 2019 Oct 1. J Clin Epidemiol. 2020. PMID: 31585174 Review.
Inappropriate methods of analysis to protect against potential negative effects from interactions were common, with 18 trials (18%) choosing the analysis method based on a preliminary test for interaction, and 13% (n = 10/75) of those conducting a factorial analysis including an …
Inappropriate methods of analysis to protect against potential negative effects from interactions were common, with 18 trials (18%) choosing …
Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT.
Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, McCabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, McKane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D. Selby PJ, et al. Among authors: altman dg. Southampton (UK): NIHR Journals Library; 2018 Jun. Southampton (UK): NIHR Journals Library; 2018 Jun. PMID: 29995365 Free Books & Documents. Review.
The ELUCIDATE trial was slow to start and recruit to, with a late surge of recruitment, and so final conclusions about the impact of the ELF test on long-term outcomes await further follow-up. The findings from the three workstreams were used to synthesise a strategy and f …
The ELUCIDATE trial was slow to start and recruit to, with a late surge of recruitment, and so final conclusions about the impact of the ELF …
Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial).
Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Angelini GD, Flather M, Taggart DP; ART (Arterial Revascularization Trial) Investigators. Benedetto U, et al. Among authors: altman dg. J Am Heart Assoc. 2018 Mar 3;7(5):e007570. doi: 10.1161/JAHA.117.007570. J Am Heart Assoc. 2018. PMID: 29502105 Free PMC article.
We investigated the association between perioperative aprotinin administration and short-term (in-hospital) and long-term outcomes by performing a post hoc analysis of the ART. ...
We investigated the association between perioperative aprotinin administration and short-term (in-hospital) and long-term outc …
Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial.
Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Flather M, Taggart DP; Arterial Revascularization Trial investigators. Benedetto U, et al. Among authors: altman dg. J Thorac Cardiovasc Surg. 2018 Apr;155(4):1545-1553.e7. doi: 10.1016/j.jtcvs.2017.10.135. Epub 2017 Dec 23. J Thorac Cardiovasc Surg. 2018. PMID: 29366570 Free article.
BACKGROUND: The long-term effects of off-pump coronary artery bypass continue to be controversial because some studies have reported increased adverse event rates with off-pump coronary artery bypass when compared with on-pump coronary artery bypass. ...
BACKGROUND: The long-term effects of off-pump coronary artery bypass continue to be controversial because some studies have reported …
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, Eccles B, Gerty S, Durcan LT, Jones L, Evans DG, Thompson AM, Pharoah P, Easton DF, Dunning AM, Hanby A, Lakhani S, Eeles R, Gilbert FJ, Hamed H, Hodgson S, Simmonds P, Stanton L, Eccles DM. Copson ER, et al. Among authors: altman dg. Lancet Oncol. 2018 Feb;19(2):169-180. doi: 10.1016/S1470-2045(17)30891-4. Epub 2018 Jan 11. Lancet Oncol. 2018. PMID: 29337092 Free PMC article.
Clinicopathological data, and data regarding treatment and long-term outcomes, including date and site of disease recurrence, were collected from routine medical records at 6 months, 12 months, and then annually until death or loss to follow-up. ...A prespecified subgroup …
Clinicopathological data, and data regarding treatment and long-term outcomes, including date and site of disease recurrence, were co …
One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
Gray AM, Murphy J, Altman DG, Benedetto U, Campbell H, Flather M, Gerry S, Lees B, Taggart DP. Gray AM, et al. Among authors: altman dg. Heart. 2017 Nov;103(21):1719-1726. doi: 10.1136/heartjnl-2016-311058. Epub 2017 Apr 27. Heart. 2017. PMID: 28450552 Free article. Clinical Trial.
Follow-up to the primary trial endpoint of 10 years will reveal whether longer-term differences emerge in graft patency or in overall survival. ...
Follow-up to the primary trial endpoint of 10 years will reveal whether longer-term differences emerge in graft patency or in overall …
Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT).
Odutayo A, Emdin CA, Hsiao AJ, Shakir M, Copsey B, Dutton S, Chiocchia V, Schlussel M, Dutton P, Roberts C, Altman DG, Hopewell S. Odutayo A, et al. Among authors: altman dg. BMJ. 2017 Mar 14;356:j917. doi: 10.1136/bmj.j917. BMJ. 2017. PMID: 28292744 Free PMC article.
Overall, registration was marginally associated with positive study findings (adjusted risk ratio 0.87, 95% confidence interval 0.78 to 0.98), even with stratification as prospectively and retrospectively registered trials (0.87, 0.74 to 1.03 and 0.88, 0.78 to 1.00, respectively) …
Overall, registration was marginally associated with positive study findings (adjusted risk ratio 0.87, 95% confidence interval 0.78 to 0.98 …
38 results